COGT•benzinga•
Baird Maintains Neutral on Cogent Biosciences, Lowers Price Target to $8
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 27, 2025 by benzinga